Comparison of short- and long-term adverse kidney outcomes after CAR-T and auto-HSCT for DLBCL
- Paul Hanna
- Aug 3, 2022
- 1 min read
Paul Hanna, Ian Strohbehn, Daiana Moreno1 Destiny Harden, Harish Seethapathy, Shruti Gupta, Meghan Lee, Tianqi Ouyang Matthew Frigault, Meghan E Sise
For full article: https://pubmed.ncbi.nlm.nih.gov/35922564/
Summary: One year kidney outcomes (AKI and CKD) were no different among pts receiving CAR-T vs Auto Stem Cell transplant: we need strategies to prevent AKI and slow eGFR decline in cancer survivors

Comments